Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Polak · SciRah

Researcher profile · Semantic Scholar

M. Polak

Share profile

M. Polak — researcher profile on SciRah

h-index: 12
Works: 36
Citations: 536

Most-cited papers

A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer
P. Konstantinopoulos, Elizabeth K. Lee, N. Xiong, C. Krasner +17 more
2022Journal of Clinical Oncology76 citations
Semantic Scholar
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
P. Konstantinopoulos, A. D. da Costa, D. Gulhan, Elizabeth K. Lee +15 more
2021Nature Communications58 citations Open access
Semantic Scholar
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
F. Batalini, N. Xiong, N. Tayob, M. Polak +11 more
2022Clinical Cancer Research54 citations Open access
Semantic Scholar
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
P. Konstantinopoulos, A. Gockley, N. Xiong, C. Krasner +20 more
2022JAMA Oncology50 citations Open access
Semantic Scholar
Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations
Emily S. Wan, A. Kantorowski, M. Polak, R. Kadri +4 more
2020Respiratory Medicine44 citations Open access
Semantic Scholar
A randomised trial of a web-based physical activity self-management intervention in COPD
S. Robinson, J. A. Cooper, R. Goldstein, M. Polak +7 more
2021ERJ Open Research43 citations Open access
Semantic Scholar
Mutational signature 3 detected from clinical panel sequencing is associated with responses to olaparib in breast and ovarian cancers
F. Batalini, D. Gulhan, V. Mao, Antuan V Tran +15 more
2022Clinical Cancer Research38 citations Open access
Semantic Scholar
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
P. Konstantinopoulos, Su-Chun Cheng, J. Supko, M. Polak +19 more
2021British Journal of Cancer33 citations Open access
Semantic Scholar
Performance of bioelectrical impedance analysis compared to dual X-ray absorptiometry (DXA) in Veterans with COPD
Paola N. Cruz Rivera, R. Goldstein, M. Polak, A. Lazzari +2 more
2022Scientific Reports22 citations Open access
Semantic Scholar
Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses
P. Konstantinopoulos, Su-Chun Cheng, Elizabeth K. Lee, A. D. da Costa +16 more
2024JCO Precision Oncology21 citations Open access
Semantic Scholar
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
E. Stover, N. Xiong, A. Myers, N. Tayob +15 more
2022Gynecologic Oncology Reports16 citations Open access
Semantic Scholar
Vitamin D, diet, and lifestyle in a chronic SCI population
Nicholas E. Koutrakis, R. Goldstein, P. Walia, M. Polak +4 more
2018Spinal Cord14 citations Open access
Semantic Scholar
Abstract CT008: A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer
Rebecca L. Porter, N. Xiong, N. Tayob, M. Polak +13 more
2024Cancer Research11 citations
Semantic Scholar
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial
P. Konstantinopoulos, Ningxuan Zhou, R. Penson, T. Le +19 more
2025Nature Communications10 citations Open access
Semantic Scholar
A Phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib
Joyce F. Liu, N. Xiong, R. Wenham, A. Wahner Hendrickson +17 more
2024Gynecologic Oncology9 citations Open access
Semantic Scholar
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer
Panagiotis A. Konstantinopoulos, M. Cai, Elizabeth K. Lee, Carolyn N. Krasner +16 more
2025JCO Precision Oncology7 citations
Semantic Scholar
Phase 2 study of letrozole, abemaciclib, and metformin in estrogen receptor (ER)–positive recurrent endometrial cancer (EC).
Panagiotis A. Konstantinopoulos, Ningxuan Zhou, R. Penson, Susana M. Campos +15 more
2025Journal of Clinical Oncology5 citations Open access
Semantic Scholar
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer
P. Konstantinopoulos, N. Xiong, C. Krasner, Joyce F. Liu +10 more
2024Gynecologic Oncology Reports5 citations Open access
Semantic Scholar
Physical Activity, Exercise Capacity, and Body Composition in U.S. Veterans with Chronic Obstructive Pulmonary Disease (COPD).
Emily S. Wan, M. Polak, R. Goldstein, A. Lazzari +3 more
2022Annals of the American Thoracic Society5 citations
Semantic Scholar
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial
Rebecca L. Porter, Yinglu Zhou, Nebiyat Eskndir, Martin Hayes +17 more
2026Nature Communications3 citations Open access
Semantic Scholar
Phase 2, two-stage study of avelumab and axitinib in patients with mismatch repair proficient recurrent or persistent endometrial cancer.
Elizabeth K. Lee, N. Xiong, Carolyn N. Krasner, M. Polak +23 more
2025Gynecologic Oncology3 citations
Semantic Scholar
Randomized phase 2 study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: Final overall survival (OS) and biomarker analyses.
P. Konstantinopoulos, Elizabeth K. Lee, Suchun Cheng, A. D. da Costa +15 more
2023Journal of Clinical Oncology3 citations Open access
Semantic Scholar
A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) endometrial cancer (EC).
R. Porter, J. Veneris, N. Tayob, Gabriela West +10 more
20213 citations
Semantic Scholar
Abstract B041: A phase 1 study of DS-8201a in combination with olaparib in HER2-expressing malignancies (CTEP #10355): Results of module 1 dose escalation
Elizabeth K. Lee, A. Wahner Hendrickson, G. Colón-Otero, Cheryl A. Pickett +8 more
2023Molecular Cancer Therapeutics2 citations
Semantic Scholar
TP015/#1566 A phase 2, two-stage, study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer (EC)
R. Porter, N. Tayob, M. Polak, Hannah R Sawyer +10 more
2022E-Posters (Trials In Progress)2 citations Open access
Semantic Scholar
Abstract 156: Mutational signature 3 predicts responses to olaparib plus buparlisib in triple-negative breast cancer and high-grade serous ovarian cancer
F. Batalini, D. Gulhan, V. Mao, M. Polak +6 more
2021Bioinformatics and Systems Biology2 citations
Semantic Scholar
Phase II study of letrozole, abemaciclib and metformin in estrogen receptor-positive recurrent endometrial cancer
Panagiotis A. Konstantinopoulos, Ningxuan Zhou, R. Penson, Susana Campos +15 more
2025Gynecologic Oncology1 citations
Semantic Scholar
Serial circulating tumor DNA (ctDNA) sequencing to monitor response and define acquired resistance to letrozole/abemaciclib in endometrial cancer (EC).
Panagiotis A. Konstantinopoulos, M. Cai, Elizabeth K. Lee, N. Xiong +16 more
2024Journal of Clinical Oncology1 citations
Semantic Scholar
Phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer (072)
P. Konstantinopoulos, Elizabeth K. Lee, N. Xiong, C. Krasner +13 more
2022Gynecologic Oncology1 citations
Semantic Scholar
Abstract CT035: CTEP #10355 A phase 1 trial of DS-8201a and olaparib in HER2-expressing malignancies: Results from dose escalation
Elizabeth K. Lee, A. W. Hendrickson, Gerardo Colon-Otero, Cheryl A. Pickett +8 more
2026Cancer Research0 citations
Semantic Scholar
Transcriptional signatures indicating RB function correlate with response to CDK4/6 inhibition in endometrial cancer.
Zelei Yang, U. Bhattarai, Martin Hayes, Elizabeth S Partan +10 more
2026Clinical Cancer Research0 citations Open access
Semantic Scholar
Abstract B012: Clinical trial of an implantable microdevice to evaluate drug responses in ovarian cancer
Elizabeth H. Stover, Sharath K. Bhagavatula, Christine A. Dominas, Sebastian W. Ahn +15 more
2025Cancer Research0 citations
Semantic Scholar
A phase II, two-stage study of avelumab and axitinib among patients with mismatch repair proficient recurrent or persistent endometrial cancer: Final efficacy analysis and correlative studies
Elizabeth Lee, N. Xiong, Su-Chun Cheng, M. Polak +15 more
2024Gynecologic Oncology0 citations
Semantic Scholar
Abstract A011: An implantable microdevice to interrogate responses to therapy in ovarian cancer
Elizabeth H. Stover, Zuzana Tatarova, Sharath K. Bhagavatula, Christine A. Dominas +14 more
2024Cancer Research0 citations
Semantic Scholar
Abstract B013: Folate receptor alpha (FRa) expression and correlation with other molecular alterations in high grade serous endometrial cancer (EC)
Rebecca L. Porter, Sandy Elias, N. Xiong, M. Polak +14 more
2024Clinical Cancer Research0 citations
Semantic Scholar
Performance of Bioelectrical Impedance Analysis Compared to DEXA in Individuals with COPD
P. N. Cruz Rivera, R. Goldstein, M. Polak, M. Moy +1 more
2019B44. COPD: TREATMENT AND OTHER TOPICS0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Hannah R Sawyer×19
Invite
Hannah R Sawyer — researcher profile on SciRah
P. Konstantinopoulos×15
Invite
P. Konstantinopoulos — researcher profile on SciRah
N. Xiong×15
Invite
N. Xiong — researcher profile on SciRah
U. Matulonis×14
Invite
U. Matulonis — researcher profile on SciRah

×13

Invite

Martin Hayes — researcher profile on SciRah

Su-Chun Cheng×13

Invite

Su-Chun Cheng — researcher profile on SciRah

U. Matulonis×13

Invite

U. Matulonis — researcher profile on SciRah

Invite

N. Tayob — researcher profile on SciRah

Joyce F. Liu×9

Invite

Joyce F. Liu — researcher profile on SciRah

S. Bouberhan×9

Invite

S. Bouberhan — researcher profile on SciRah

Invite

R. Penson — researcher profile on SciRah

Elizabeth K. Lee×9

Invite

Elizabeth K. Lee — researcher profile on SciRah